Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
How did CALA's recent EPS compare to expectations?
The most recent EPS for Calithera Biosciences Inc is $, expectations of $-0.28.
How did Calithera Biosciences Inc CALA's revenue perform in the last quarter?
Calithera Biosciences Inc revenue for the last quarter is $
What is the revenue estimate for Calithera Biosciences Inc?
According to of Wall street analyst, the revenue estimate of Calithera Biosciences Inc range from $ to $
What's the earning quality score for Calithera Biosciences Inc?
Calithera Biosciences Inc has a earning quality score of A-/58.03419. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Calithera Biosciences Inc report earnings?
Calithera Biosciences Inc next earnings report is expected in 2024-06-27
What are Calithera Biosciences Inc's expected earnings?
Calithera Biosciences Inc expected earnings is $0.0, according to wall-street analysts.
Did Calithera Biosciences Inc beat earnings expectations?
Calithera Biosciences Inc recent earnings of $ expectations.